This series describes the cases of three patients with BRAF V600-mutated CNS tumors in whom BRAF-targeted therapy was utilized, including one of the first reported cases of response to targeted therapy in BRAF V600E-mutated RDD. Here, BRAF is linked to central nervous system neoplasm.